Printer Friendly

Browse Duchenne muscular dystrophy topic

Articles

1-144 out of 144 article(s)
Title Author Type Date Words
Pfizer Doses First Participant in Phase 3 Study for Duchenne Muscular Dystrophy Investigational Gene Therapy. Jan 7, 2021 581
Amber Specialty Pharmacy Selected by PTC Therapeutics to Dispense Emflaza for Duchenne Muscular Dystrophy Patients. Oct 12, 2020 309
Italfarmaco Receives FDA Rare Pediatric Disease Designation for Givinostat in Duchenne Muscular Dystrophy, Announces Completed Enrollment in EPIDYS Phase 3 Trial. Oct 12, 2020 586
Pfizer Receives FDA Fast Track Designation for Duchenne Muscular Dystrophy Investigational Gene Therapy. Oct 2, 2020 345
FDA approves viltolarsen for Duchenne muscular dystrophy. Brooks, Megan Oct 1, 2020 375
Pharmaxis awarded A$1 million to progress Duchenne Muscular Dystrophy drug into the clinic. Sep 4, 2020 758
US FDA approves NS Pharma's Viltepso (viltolarsen) Duchenne muscular dystrophy injection. Aug 13, 2020 216
US FDA approves NS Pharma's Viltepso (viltolarsen) Duchenne muscular dystrophy injection. Aug 13, 2020 212
Duchenne Muskuler Distrofi ve Spinal Muskuler Atrofi Tanisi Alan Pediyatrik Hastalarda Uykunun Yapisinin ve Uyku ile Iliskili Hastaliklarin Incelenmesi/Evaluation of Sleep Structure and Sleep-related Disorders in Pediatric Patients Diagnosed with Duchenne Muscular Dystrophy and Spinal Muscular Atrophy. Arkali, Nuran Burcu; Senel, Gulcin Benbir; Kilic, Huseyin; Incesu, Gunduz; Saltik, Sema; Yalcinkaya, Disease/Disorder overview Mar 1, 2020 2918
Orsini Pharmaceutical Services Selected to Provide Vyondys 53 Injection for Duchenne Muscular Dystrophy. Feb 11, 2020 207
Roche enters licensing agreement with Sarepta Therapeutics to improve the lives of patients living with Duchenne muscular dystrophy. Dec 23, 2019 867
Spironolactone Noninferior in Duchenne Muscular Dystrophy; Spironolactone noninferior to eplerenone for preserving cardiac contractility in boys with Duchenne. Oct 28, 2019 237
Catabasis Pharmaceuticals Presents Edasalonexent, a Potential Foundational Treatment for Duchenne Muscular Dystrophy. Oct 9, 2019 544
Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market by Type & Geography (2019-2023). Sep 10, 2019 739
The relationship of bone mineral density and vitamin D levels with steroid use and ambulation in patients with Duchenne muscular dystrophy. Sertpoyraz, Filiz Meryem; Tiftikcioglu, Bedile Irem Sep 1, 2019 3629
Sarepta Plunges After FDA Spurns Its Second Duchenne Muscular Dystrophy Drug. Aug 20, 2019 408
Global Duchenne Muscular Dystrophy Drugs Market Report, 2019-2025 - Mutation Suppression Displays the Potential to Grow at Over 40.2%. Report Aug 7, 2019 714
Pfizer Presents Initial Clinical Data on Phase 1b Gene Therapy Study for Duchenne Muscular Dystrophy. Jul 2, 2019 954
Catabasis Pharmaceuticals Presents Preclinical Data Showing Potential for Bone Preservation with Edasalonexent in Duchenne Muscular Dystrophy. Jun 27, 2019 780
Global Duchenne Muscular Dystrophy (DMD) Market Spotlight 2017-2018 & 2019-2026. Jun 19, 2019 903
Universal Credit 'error' leaves parents of terminally ill girl with 'nothing'; Brendan and Kelly-Anne Shortall say they don't have enough money to take their daughter Hannah, who has Duchenne muscular dystrophy, on a day out. May 30, 2019 825
Biochemical Changes in Blood of Patients with Duchenne Muscular Dystrophy Treated with Granulocyte-Colony Stimulating Factor. Sienkiewicz, Dorota; Kulak, Wojciech; Paszko-Patej, Grazyna; Okurowska-Zawada, Bozena; Sienkiewicz, Mar 31, 2019 4247
Catabasis Pharmaceuticals Presents Data Supporting Edasalonexent as a Potential Foundational Treatment for Duchenne Muscular Dystrophy. Feb 20, 2019 671
Researchers Discover A Way To Treat Duchenne Muscular Dystrophy. Feb 11, 2019 471
Charity boxing night set to raise funds for young boy with a degenerative disease; Proceeds will help fund equipment for Jenson Edwards who was diagnosed with Duchenne muscular dystrophy at three and is likely to be wheelchair-bound by 11. Dec 2, 2018 268
Catabasis Pharmaceuticals Publishes Phase 1 Clinical Results of Edasalonexent (CAT-1004) in Duchenne Muscular Dystrophy. Nov 29, 2018 490
Catabasis Pharmaceuticals Starts Phase 3 PolarisDMD Clinical Trial for Edasalonexent in Duchenne Muscular Dystrophy. Sep 26, 2018 627
Pfizer to halt two trials for treatment of Duchenne muscular dystrophy. Sep 3, 2018 154
Pfizer to halt two trials for treatment of Duchenne muscular dystrophy. Sep 3, 2018 150
CRISPR Halts Duchenne Muscular Dystrophy. Sep 2, 2018 592
Pfizer Terminates Domagrozumab Clinical Studies for the Treatment of Duchenne Muscular Dystrophy. Clinical report Aug 31, 2018 563
PTC Therapeutics Publishes Data Demonstrating Benefit of Deflazacort in Duchenne Muscular Dystrophy. Clinical report Jul 26, 2018 356
Grandfather walking 500 miles to help three-year-old grandson with life-limiting illness; Three-year-old Lincoln was dagnosed in December 2016 with Duchenne Muscular Dystrophy (DMD). Jun 22, 2018 470
Results of Catabasis Pharmaceuticals Trial of Edasalonexent in Duchenne Muscular Dystrophy to be Presented at American Academy of Neurology 70th Annual Meeting. Apr 20, 2018 246
Molecular Analysis-Based Genetic Characterization of a Cohort of Patients with Duchenne and Becker Muscular Dystrophy in Eastern China. Zhao, Hui-Hui; Sun, Xue-Ping; Shi, Ming-Chao; Yi, Yong-Xiang; Cheng, Hong; Wang, Xing-Xia; Xu, Qing- Report Apr 15, 2018 4188
US EAP for Idebenone for Duchenne Muscular Dystrophy Patients Launched by Clinigen and Santhera. Feb 22, 2018 259
Mum's heartbreaking poem for terminally ill son made into everlasting memory; Seven-year-old Toby suffers with Duchenne Muscular Dystrophy (DMD). Jan 21, 2018 669
Gestational Outcomes of Pregnant Women Who Have Had Invasive Prenatal Testing for the Prenatal Diagnosis of Duchenne Muscular Dystrophy. Beksac, Mehmet Sinan; Tanacan, Atakan; Hakli, Duygu Aydin; Orgul, Gokcen; Soyak, Burcu; Hayta, Burcu Jan 1, 2018 3293
Fat Embolism Syndrome in Duchenne Muscular Dystrophy Patients: Early Recognition and Aggressive Therapy. Murphy, Lee D.; Yabrodi, Mouhammad; Lutfi, Riad Jan 1, 2018 1935
Wave Life Sciences Commences Clinical Trial of WVE-210201 in Boys 5 to 18 Years Old with Duchenne Muscular Dystrophy. Clinical report Nov 7, 2017 394
Capricor Presents 12-Month Results from HOPE-1 Trial in Duchenne Muscular Dystrophy. Oct 25, 2017 392
Relevant aspects of golden retriever muscular dystrophy for the study of Duchenne muscular dystrophy in humans/Aspectos relevantes da distrofia muscular do golden retriever para o estudo da distrofia muscular de Duchenne em humanos. de Moraes, Julieta Rodini Engracia; Malvestio, Lygia Maria Mouri; Martins, Isabela Mancini; Mosko, P Ensayo Oct 1, 2017 7455
Capricor Therapeutics Names PI for Clinical Trial of CAP-1002 in Duchenne Muscular Dystrophy. Sep 27, 2017 359
FDA Indicates Willingness to Accept Capricor's Proposed Clinical Development Plan for Intravenous CAP-1002 for Duchenne Muscular Dystrophy. Jul 28, 2017 342
ASSOCIATION OF DEVELOPMENTAL DELAY, CONGENITAL ADRENAL HYPOPLASIA, DUCHENNE MUSCULAR DYSTROPHY AND GLYCEROL KINASE DEFICIENCY: A RARE Xp21 CONTIGUOUS GENE DELETION SYNDROME. Altundag, Engin; Kara, Cengiz; Sanri, Aslihan; Albayrak, Hatice Mutlu; Yalcin, Hatice Yelda; Ogur, G Case study Jun 1, 2017 328
Six-month results from clinical trial in duchenne muscular dystrophy. May 1, 2017 806
Six-month results from clinical trial in duchenne muscular dystrophy. May 1, 2017 805
Catabasis Pharmaceuticals Touts Favourable Functional Assessment Results in MoveDMD Trial for Edasalonexent in Duchenne Muscular Dystrophy. Apr 25, 2017 624
Nicotinamide riboside shows promise for Duchenne muscular dystrophy. Report Apr 1, 2017 234
Characterization of a Blood Spot Creatine Kinase Skeletal Muscle Isoform Immunoassay for High-Throughput Newborn Screening of Duchenne Muscular Dystrophy. Moat, Stuart J.; Korpimaki, Teemu; Furu, Petra; Hakala, Harri; Polari, Hanna; Merio, Liisa; Makinen, Report Apr 1, 2017 4492
Solid Biosciences Raises up to USD 50m; Will Use for Duchenne Muscular Dystrophy Portfolio. Mar 31, 2017 301
PTC Therapeutics to purchase Emflaza for the treatment of Duchenne Muscular Dystrophy in the US from Marathon. Mar 17, 2017 278
PTC Therapeutics to purchase Emflaza for the treatment of Duchenne Muscular Dystrophy in the US from Marathon. Mar 17, 2017 274
Catabasis Pharmaceuticals Posts Mixed Top-Line Results for Part B of Trial for Edasalonexent in Duchenne Muscular Dystrophy. Feb 1, 2017 288
Cellular Reprogramming, Genome Editing, and Alternative CRISPR Cas9 Technologies for Precise Gene Therapy of Duchenne Muscular Dystrophy. Gee, Peter; Xu, Huaigeng; Hotta, Akitsu Report Jan 1, 2017 8333
A Reduction in Selenoprotein S Amplifies the Inflammatory Profile of Fast-Twitch Skeletal Muscle in the mdx Dystrophic Mouse. Craig, Robert Wright; Allsopp, Giselle Larissa; Addinsall, Alex Bernard; McRae, Natasha Lee; Andriko Report Jan 1, 2017 7003
Induction of Pluripotent Stem Cells from a Manifesting Carrier of Duchenne Muscular Dystrophy and Characterization of Their X-Inactivation Status. Miyagoe-Suzuki, Yuko; Nishiyama, Takashi; Nakamura, Miho; Narita, Asako; Takemura, Fusako; Masuda, S Report Jan 1, 2017 5342
Sarepta Therapeutics receives EMA validation of eteplirsen's MAA for Duchenne Muscular Dystrophy amenable to exon skipping 51. Dec 20, 2016 299
Sarepta Therapeutics receives EMA validation of eteplirsen's MAA for Duchenne Muscular Dystrophy amenable to exon skipping 51. Dec 20, 2016 303
Company finishes enrollment in Duchenne muscular dystrophy trial. Sep 12, 2016 378
My family's journey with Duchenne muscular dystrophy; as we wait to see what will happen, I take each day as it comes and continue to fight to make sure my boys will have access to this drug--it is our only hope at this stage. Vertin, Betty Aug 1, 2016 1469
Biomarin's regulatory submissions for Kyndrisa Duchenne muscular dystrophy drug withdrawn. Jun 2, 2016 187
Biomarin's regulatory submissions for Kyndrisa Duchenne muscular dystrophy drug withdrawn. Jun 2, 2016 183
PTC Therapeutics announces NICE's recommendation for Translarna (ataluren) for treating nonsense mutation Duchenne Muscular Dystrophy in England. Apr 18, 2016 302
PTC Therapeutics announces NICE's recommendation for Translarna (ataluren) for treating nonsense mutation Duchenne Muscular Dystrophy in England. Apr 18, 2016 298
DEVASTATING; Families' despair as watchdogs turn down PS200k-a-year Duchenne muscular dystrophy treatment that transformed their boys' lives. Apr 12, 2016 290
Just Published: "Duchenne Muscular Dystrophy - Pipeline Review, H1 2016". Apr 8, 2016 480
PTC Therapeutics introduces second annual STRIVE rant award programme for Duchenne muscular dystrophy. Feb 15, 2016 192
PTC Therapeutics introduces second annual STRIVE rant award programme for Duchenne muscular dystrophy. Feb 15, 2016 188
Stem cell gene therapy could be key to treating Duchenne muscular dystrophy. Feb 1, 2016 781
Now Available: Duchenne Muscular Dystrophy - Pipeline Review, H2 2015. Jan 20, 2016 480
Scientists stop Duchenne muscular dystrophy with gene editing. Jan 1, 2016 258
Duchenne muscular dystrophy is a genetic stem cell disease. Nov 23, 2015 477
World Duchenne Awareness Day: Anger as Blyth parents told of child's illness over the phone; A Northumberland dad has called on the Government to do more to help families of children suffering with Duchenne muscular dystrophy. Sep 7, 2015 543
Mum's Facebook appeal sees boy with rare muscle wasting condition receive 8,000 birthday cards; William Magee, who turns six on Wednesday, suffers from Duchenne Muscular Dystrophy, a genetic, terminal, muscle wasting condition. Aug 14, 2015 447
Carrier screening for Duchenne muscular dystrophy. Aug 1, 2015 1937
NHS delays Newcastle drug used to tackle a rare muscle-wasting condition; NHS England has halted the assessment of new Newcastle treatment Translarna used for boys with Duchenne muscular dystrophy. Jul 3, 2015 602
Phrixus Pharmaceuticals Receives Services From National Institutes of Health, NHLBI SMARTT Program to Produce Carmeseal-MD(TM) for Clinical Trial to Treat Duchenne Muscular Dystrophy. Jun 18, 2015 290
Blyth boy George Pegg delivers letter to Prime Minister in Muscular Dystrophy drug appeal; The 11-year-old Duchenne muscular dystrophy sufferer urged David Cameron to make the drug Translarna widely available. Jun 10, 2015 821
Duchenne muscular dystrophy diagnostics: it only gets better but some of the same challenges remain. Prior, Thomas W. Editorial Jun 1, 2015 1509
Noninvasive prenatal diagnosis of Duchenne muscular dystrophy: comprehensive genetic diagnosis in carrier, proband, and fetus. Yoo, Seong-Keun; Lim, Byung Chan; Byeun, Jiyoung; Hwang, Hee; Kim, Ki Joong; Hwang, Yong Seung; Lee, Report Jun 1, 2015 4893
Dystrophin hydrophobic regions in the pathogenesis of Duchenne and Becker muscular dystrophies. Liang, Yingyin; Chen, Songlin; Zhu, Jianzong; Zhou, Xiangxue; Yang, Chen; Yao, Lu; Zhang, Cheng Report May 1, 2015 5456
EpiCast Report: Duchenne Muscular Dystrophy - Epidemiology Forecast to 2023 - New Report Available. Apr 29, 2015 638
"Duchenne Muscular Dystrophy - Pipeline Review, H1 2015" now available at Fast Market Research. Mar 27, 2015 559
Bikers' [pounds sterling]10k pledge to help Sunderland youngster with Duchenne muscular dystrophy; Family of nine-year-old Matthew Brettell hoping to raise total of [pounds sterling]75,000 to adapt family home in Sunderland. Feb 3, 2015 612
Stem cells are defective in Duchenne muscular dystrophy. Jan 19, 2015 337
PTC Therapeutics begins rolling submission of Translarna's NDA to the US FDA for treating nonsense mutation Duchenne muscular dystrophy. Dec 24, 2014 238
PTC Therapeutics begins rolling submission of Translarna's NDA to the US FDA for treating nonsense mutation Duchenne muscular dystrophy. Dec 24, 2014 234
North expert's appeal to NHS over Duchenne treatment drug; WHAT IS DUCHENNE MUSCULAR DYSTROPHY? Dec 3, 2014 1435
Healing heart damage caused by Duchenne muscular dystrophy. Clinical report Nov 24, 2014 296
Duchenne muscular dystrophy: high-resolution melting curve analysis as an affordable diagnostic mutation scanning tool in a South African cohort. Esterhuizen, A.I.; Wilmshurst, J.M.; Goliath, R.G.; Greenberg, L.J. Nov 1, 2014 4343
Prosensa begins drisapersen's NDA submission to the US FDA for Duchenne muscular dystrophy. Oct 13, 2014 223
Prosensa begins drisapersen's NDA submission to the US FDA for Duchenne muscular dystrophy. Oct 13, 2014 219
Capricor to pursue clinical program for treatment of Duchenne muscular dystrophy. Oct 6, 2014 160
Capricor to pursue clinical program for treatment of Duchenne muscular dystrophy. Oct 6, 2014 160
'Early diagnosis has helped us plan for Alex's future' REAL LIFE STORIES Alex George was just a few days old when he was diagnosed with Duchenne muscular dystrophy after a simple heel prick test as a newborn. Mum Jeanette tells RACHEL MAINWARING why the early diagnosis, although a shock, meant they could plan for his future. May 20, 2014 1186
Viagra can treat Duchenne muscular dystrophy. May 8, 2014 144
Ward seeking to find cure to Duchenne muscular dystrophy with two-year grant. Feb 1, 2014 271
Corticosteroid treatment impact on spinal deformity in Duchenne muscular dystrophy. Sanzarello, Ilaria; Merlini, Luciano; Traina, Francesco; Rosa, Michele Attilio; Faldini, Cesare Report Jan 1, 2014 6948
Genetic testing for Duchenne/Becker muscular dystrophy in Johannesburg, South Africa. Kerr, R.; Robinson, C.; Essop, F.B.; Krause, A. Report Dec 1, 2013 4459
PPMD, Sarepta to launch programme for genetic testing of Duchenne muscular dystrophy patients in Q4 2013. Oct 21, 2013 138
Prosensa Holding NV's fourth exon-skipping compound PRO053 in clinical study for Duchenne muscular dystrophy. Clinical report Sep 9, 2013 259
Prosensa Holding NV's fourth exon-skipping compound PRO053 in clinical study for Duchenne muscular dystrophy. Clinical report Sep 9, 2013 245
Prosensa Holding NV secures EUR6m EU FP7 research grant for PRO045 for Duchenne muscular dystrophy. Aug 2, 2013 234
Prosensa Holding NV secures EUR6m EU FP7 research grant for PRO045 for Duchenne muscular dystrophy. Aug 2, 2013 230
New Plush Toy Cures the Smelly Gym Bag, Proceeds Benefit Duchenne Muscular Dystrophy Charity. Mar 26, 2013 447
Daiichi Sankyo Develops Nucleic Acid Treatment for Duchenne Muscular Dystrophy. Feb 18, 2013 228
Stem cell approach shows promise for Duchenne muscular dystrophy. Jan 21, 2013 563
Coenzyme Q10 for Duchenne muscular dystrophy. Gaby, Alan R. Brief article Jul 1, 2012 214
Dependence on care experienced by people living with Duchenne muscular dystrophy and spinal cord injury. Martinsen, Bente; Dreyer, Pia Report Apr 1, 2012 7138
FEASIBILITY OF SHORT TANDEM REPEATS (STR) ANALYSIS FOR CARRIER DETECTION AND PRENATAL DIAGNOSIS IN FAMILIES WITH DUCHENNE MUSCULAR DYSTROPHY (DMD). Shaheen, Sajida; Ahmad, Suhaib; Hashim, Rizwan; Sattar, Abdus; Khan, Farooq Ahmad Report Dec 31, 2011 2694
Santhera's Catena slows decline in respiratory function in Duchenne Muscular Dystrophy. Clinical report Oct 19, 2011 115
AVI BioPharma Inc initiates Phase 2 trial of eteplirsen in higher doses in Duchenne muscular dystrophy patients. Aug 16, 2011 162
Molecular therapy promises treatment of Duchenne muscular dystrophy. Jul 26, 2011 328
Great Ormond Street Hospital patients take part in Duchenne Muscular Dystrophy clinical trial. Jul 26, 2011 643
Great Ormond Street Hospital patients take part in Duchenne Muscular Dystrophy clinical trial. Jul 26, 2011 643
Santhera presents promising data from Catena's DELPHI-E study in Duchenne Muscular Dystrophy. May 9, 2011 298
A medical approach to the care of children with Duchenne muscular dystrophy. Wilmshurst, Jo Apr 1, 2011 1049
Researchers find that Duchenne muscular dystrophy is basically a stem cell disease. Dec 13, 2010 776
Prosensa receives GBP7.5m milestone payment under programme with GlaxoSmithKline for Duchenne Muscular Dystrophy. Oct 13, 2010 154
AMT's gene therapy gains FDA Orphan Drug status for Duchenne muscular dystrophy. Sep 24, 2010 224
Use of multiplex ligation-dependent probe amplification (MLPA) for Duchenne muscular dystrophy (DMD) gene mutation analysis. M., Sakthivel Murugan S.; Chandramohan, Arthi; Lakshmi, Bremadesam Raman Report Sep 1, 2010 5344
Acceleron Pharma's ACE-031 gets FDA Fast Track designation for Duchenne Muscular Dystrophy. Aug 30, 2010 133
Acceleron gets FDA orphan designation for ACE-031 in Duchenne Muscular Dystrophy. Aug 19, 2010 171
Acceleron Pharma's ACE-031 gets FDA Fast Track designation for Duchenne Muscular Dystrophy. Aug 6, 2010 133
Gene responsible for Duchenne muscular dystrophy can be repaired. Apr 16, 2010 217
BioMarin commences Phase I study of BMN 195 in Duchenne muscular dystrophy. Jan 12, 2010 180
AMT awarded innovation credit of EUR4.0m for Duchenne Muscular Dystrophy treatment. Jan 6, 2010 233
AVI BioPharma reports Phase Ib/II data for AVI-4658 in Duchenne muscular dystrophy. Dec 23, 2009 825
Glaxo's $679 million accord signals foray into rare diseases. Brief article Oct 19, 2009 235
Prevalence of Duchenne/Becker muscular dystrophy among males aged 5-24 years--four states, 2007. Romitti, P.; Puzhankara, S.; Mathews, K.; Zamba, G.; Cunniff, C.; Andrews, J.; Matthews, D.; James, Clinical report Oct 16, 2009 2710
Omega moulding helps hope for Javier fight Duchenne Muscular Dystrophy. Brief article Oct 1, 2008 311
Quantitative assay of deletion or duplication genotype by capillary electrophoresis system: application in Prader-Willi syndrome and Duchenne muscular dystrophy. Hung, Chia-Cheng; Chen, Chih-Ping; Lin, Shuan-Pei; Chien, Shu-Chin; Lee, Chien-Nan; Cheng, Wen-Fang; Dec 1, 2006 5277
Denaturing HPLC coupled with multiplex PCR for rapid detection of large deletions in Duchenne muscular dystrophy carriers. Hung, Chia-Cheng; Su, Yi-Ning; Lin, Chia-Yun; Yang, Chih-Chao; Lee, Wang-Tso; Chien, Shu-Chin; Lin, Jul 1, 2005 2551
Toilet training. (Respond). Brief Article Feb 1, 2003 161
Evaluation of microchip electrophoresis as a molecular diagnostic method for Duchenne muscular dystrophy. Ferrance, Jerome; Snow, Karen; Landers, James P. Feb 1, 2002 2426
Meeting the challenges: pulmonary complications in Duchenne muscular dystrophy. (EP Guide To Every Body Part 8). Braverman, Jane Dec 1, 2001 2877
Clinical and experimental results on cardiac troponin expression in duchenne muscular dystrophy. Hammerer-Lercher, Angelika; Erlacher, Petra; Bittner, Reginald; Korinthenberg, Rudolf; Skladal, Dani Mar 1, 2001 5700
MEDICAL RESEARCH UPDATE. CHAMALIAN, DAVID Feb 1, 2001 761
New tools for muscular dystrophy research. Seppa, Nathan Brief Article Sep 6, 1997 534
And downs. Brief Article Oct 28, 1995 464
Steroid slackens pace of muscular dystrophy. Fackelmann, Kathy A. Apr 27, 1991 588
Foot feat: transplant treats dystrophy. Jun 16, 1990 210
Facts about muscular dystrophy. pamphlet May 1, 1990 2784

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters